Related references
Note: Only part of the references are listed.Betulinic acid improves insulin sensitivity, hyperglycemia, inflammation and oxidative stress in metabolic syndrome rats via PI3K/Akt pathways
R. A. Ajala-Lawal et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2020)
Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway
I. Snekvik et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Prevalence of metabolic syndrome and its associated factors in Chinese patients with ankylosing spondylitis
Meng Liu et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis
Zsombor Zrubka et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2019)
Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up
Patricia Shu Kurizky et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2019)
Anti-inflammatory treatment improves high-density lipoprotein function in rheumatoid arthritis
Francis O'Neill et al.
HEART (2017)
alpha-Amyrin attenuates high fructose diet-induced metabolic syndrome in rats
Pankaj Prabhakar et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2017)
Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression
Enas A. Abd El-Haleim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Infliximab therapy restores adiponectin expression in perivascular adipose tissue and improves endothelial nitric oxide-mediated vasodilation in mice with type 1 diabetes
Carmela Nacci et al.
VASCULAR PHARMACOLOGY (2016)
Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression
Enas A. Abd El-Haleim et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Fructose Beverage Consumption Induces a Metabolic Syndrome Phenotype in the Rat: A Systematic Review and Meta-Analysis
Carla R. Toop et al.
NUTRIENTS (2016)
Infliximab Modulates Cisplatin-Induced Hepatotoxicity in Rats
Medine Cumhur Cure et al.
BALKAN MEDICAL JOURNAL (2016)
Fructose: Toxic effect on cardiorenal risk factors and redox state
Fabiane V. Francisqueti et al.
SAGE OPEN MEDICINE (2016)
Protective Effects of Infliximab on Lung Injury Induced by Methotrexate
Aysel Kurt et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2015)
Impact of Metabolic Syndrome on the Hospitalization Rate of Crohn's Disease Patients Seen at a Tertiary Care Center: A Retrospective Cohort Study
Paul Stephen Fitzmorris et al.
DIGESTION (2015)
Protective effect of infliximab on methotrexate-induced liver injury in rats: Unexpected drug interaction
Erkan Cure et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2015)
Association Between Anti-TNF Therapy for Rheumatoid Arthritis and Hypertension A Meta-Analysis of Randomized Controlled Trials
Qingwei Zhao et al.
MEDICINE (2015)
Protective Effects of Infliximab on Lung Injury Induced by Methotrexate
Aysel Kurt et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2015)
Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences
K. Danielsen et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Adiponectin Resistance and Proinflammatory Changes in the Visceral Adipose Tissue Induced by Fructose Consumption via Ketohexokinase-Dependent Pathway
George Marek et al.
DIABETES (2015)
Metabolic syndrome and chronic arthritis: effects of anti-TNF-α therapy
Nicola Maruotti et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2015)
A comparison of the effects of infliximab, adalimumab, and pentoxifylline on rats with non-alcoholic steatohepatitis
Mustafa Yalcin et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2014)
Suppression of the GLUT4 adaptive response to exercise in fructose-fed rats
Veeraj Goyaram et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients
S. Yoshida et al.
JOURNAL OF HUMAN HYPERTENSION (2014)
Potential Protective Effects of Nigella Sativa and Allium Sativum Against Fructose-Induced Metabolic Syndrome in Rats
Nawal Al-Rasheed et al.
JOURNAL OF OLEO SCIENCE (2014)
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut
R. Caruso et al.
MUCOSAL IMMUNOLOGY (2014)
Ursodeoxycholic Acid Ameliorates Fructose-Induced Metabolic Syndrome in Rats
Amr A. A. Mahmoud et al.
PLOS ONE (2014)
The Establishment of Metabolic Syndrome Model by Induction of Fructose Drinking Water in Male Wistar Rats
Norshalizah Mamikutty et al.
BIOMED RESEARCH INTERNATIONAL (2014)
A Comprehensive Review on Metabolic Syndrome
Jaspinder Kaur
CARDIOLOGY RESEARCH AND PRACTICE (2014)
Chronic Administration of Infliximab (TNF-α Inhibitor) Decreases Depression and Anxiety-like Behaviour in Rat Model of Chronic Mild Stress
Ayse Karson et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2013)
Infliximab prevents increased systolic blood pressure and upregulates the AKT/eNOS pathway in the aorta of spontaneously hypertensive rats
Ademir Gazzoto Filho et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
The role of infliximab on paracetamol-induced hepatotoxicity in rats
Irmak Ferah et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2013)
Fructose toxicity: is the science ready for public health actions?
Luc Tappy et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2012)
Infliximab attenuates activated charcoal and polyethylene glycol aspiration-induced lung injury in rats
Aygul Guzel et al.
EXPERIMENTAL LUNG RESEARCH (2012)
Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats
Pankaj K. Bagul et al.
PHARMACOLOGICAL RESEARCH (2012)
Protective Effect of Infliximab on Ischemia/Reperfusion-Induced Damage in Rat Kidney
Cemal Tasdemir et al.
RENAL FAILURE (2012)
Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rats with TNBS-induced colitis
Thayane Rodrigues Leite Clemente et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Infliximab alleviates inflammation and ex vivo airway hyperreactivity in asthmatic E3 rats
Yan Cai et al.
INTERNATIONAL IMMUNOLOGY (2011)
Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis
A. Sandoo et al.
JOURNAL OF HUMAN HYPERTENSION (2011)
Neuroprotective effects of infliximab in experimental spinal cord ischemic injury
Cagatay Guven et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2010)
Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and Inflammation
Aparna Purushotham et al.
CELL METABOLISM (2009)
Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis
Christos S. Derdemezis et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2009)
Toll-Like Receptor 4 Is Involved in the Development of Fructose-Induced Hepatic Steatosis in Mice
Astrid Spruss et al.
HEPATOLOGY (2009)
Effects of Infliximab Therapy on Abdominal Fat and Metabolic Profile in Patients with Crohn's Disease
Erika Parmentier-Decrucq et al.
INFLAMMATORY BOWEL DISEASES (2009)
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
Kimber L. Stanhope et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats
Linda T. Tran et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
Dietary fructose and the metabolic syndrome
Abigale Miller et al.
CURRENT OPINION IN GASTROENTEROLOGY (2008)
A high-fructose diet impairs akt and PKCζ phosphorylation and GLUT4 translocation in rat skeletal muscle
P. Li et al.
HORMONE AND METABOLIC RESEARCH (2008)
Hepatoprotective effect of infliximab, an anti-TNF-α agent, on carbon tetrachloride-induced hepatic fibrosis
Ibrahim Halil Bahcecioglu et al.
INFLAMMATION (2008)
Effect of anti-tumor necrosis factor-α therapies on body mass index in patients with psoriasis
Rosita Saraceno et al.
PHARMACOLOGICAL RESEARCH (2008)
Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats
Yuji Moriwaki et al.
ACTA DIABETOLOGICA (2007)
Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis
Calin Popa et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet
Raquel Barbuio et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Pharmacokinetic drug-drug interaction potentials for therapeutic monoclonal antibodies: Reality check
Kathleen Seitz et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
The effect of infliximab on circulating levels of leptin, adiponectin and resistin in patients with inflammatory bowel disease
Konstantinos Karmiris et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2007)
Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis
M. J. L. Peters et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Metabolic stress with a high carbohydrate diet increases adiponectin levels
Y. Kamari et al.
HORMONE AND METABOLIC RESEARCH (2007)
Effect of PPAR-γ agonist on adiponectin levels in the metabolic syndrome:: Lessons from the high fructose fed rat model
Yehonatan Sharabi et al.
AMERICAN JOURNAL OF HYPERTENSION (2007)
A vaccine for hypertension based on virus-like particles:: preclinical efficacy and phase I safety and immunogenicity
Patrice M. Ambuehl et al.
JOURNAL OF HYPERTENSION (2007)
The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk
Calin Popa et al.
JOURNAL OF LIPID RESEARCH (2007)
Effect of fructose-rich high-fat diet on glucose sensitivity and atherosclerosis in nonhuman primate
M. Suzuki et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2006)
Mechanisms of insulin resistance in hypertensive rats
Kazuaki Shimamoto et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2006)
Favorable response to subcutaneous administration of infliximab in rats with experimental colitis
John K. Triantafillidis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis
S Van Doornum et al.
RHEUMATOLOGY (2005)
Consuming fructose-sweetened beverages increases body adiposity in mice
H Jürgens et al.
OBESITY RESEARCH (2005)
Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis
C Popa et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes
H Dominguez et al.
JOURNAL OF VASCULAR RESEARCH (2005)
Definition of metabolic syndrome - Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition
SM Grundy et al.
CIRCULATION (2004)
Infliximab:: mechanism of action beyond TNF-α neutralization in inflammatory bowel disease
I Kirman et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
Lipoic acid attenuates hypertension and improves insulin sensitivity, kallikrein activity and nitrite levels in high fructose-fed rats
V Thirunavukkarasu et al.
JOURNAL OF COMPARATIVE PHYSIOLOGY B-BIOCHEMICAL SYSTEMS AND ENVIRONMENTAL PHYSIOLOGY (2004)
Effect of anti TNFalpha therapy on arterial diameter and wall shear stress and HDL cholesterol
C Irace et al.
ATHEROSCLEROSIS (2004)
The metabolic syndrome: prevalence in worldwide populations
AJ Cameron et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2004)
Share Paper
